Article Details
Retrieved on: 2021-07-17 11:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New Delhi: In response to the drug maker Lupin's proposal to conduct a PhaseII/III Clinical Trial protocol for Remdesivir Powder for Inhalation, the ...
Article found on: medicaldialogues.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here